AU2012201226B2 — Sustained local anesthetic composition containing preferably a sugar ester such as SAIB
Assigned to Durect Corp · Expires 2014-08-14 · 12y expired
What this patent protects
The present invention relates to novel anesthetic compositions containing a non polymeric carrier material and an anesthetic, where the compositions are suitable for providing a sustained local anesthesia without an initial burst and having a duration for about 24 hours or longer…
USPTO Abstract
The present invention relates to novel anesthetic compositions containing a non polymeric carrier material and an anesthetic, where the compositions are suitable for providing a sustained local anesthesia without an initial burst and having a duration for about 24 hours or longer. Certain compositions are also provided that include a first anesthetic and a second anesthetic. In such compositions, the second anesthetic is a solvent for the first anesthetic and provides an initial anesthetic effect upon administration to a subject. The non-polymeric carrier may optionally be a high viscosity liquid carrier material such as a suitable sugar ester. The compositions can further include one or more additional ingredients including active and inactive materials. Methods of using the compositions of the invention to produce a sustained anesthetic effect at a site in a subject are also provided. Preferably the composition contains bupivacaine and a sugar ester such as saib. -~First supplemental algsc(Avg) c 25 0 10 2 0 3 0 4 0 5 0 6 0 70 80 90 Time (Hours) -.- SABER Buplv + Saline --- SABER Bupiv + Buplv -A Bupiv + Bupiv
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.